Anti-IL27A/ IL27/ IL-27 functional antibody

Anti-IL27A/ IL27/ IL-27 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to IL27/IL27 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1026-Ab-1/ GM-Tg-hg-SE1026-Ab-2Anti-Human IL27 monoclonal antibodyHuman
GM-Tg-rg-SE1026-Ab-1/ GM-Tg-rg-SE1026-Ab-2Anti-Rat IL27 monoclonal antibodyRat
GM-Tg-mg-SE1026-Ab-1/ GM-Tg-mg-SE1026-Ab-2Anti-Mouse IL27 monoclonal antibodyMouse
GM-Tg-cynog-SE1026-Ab-1/ GM-Tg-cynog-SE1026-Ab-2Anti-Cynomolgus/ Rhesus macaque IL27 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1026-Ab-1/ GM-Tg-felg-SE1026-Ab-2Anti-Feline IL27 monoclonal antibodyFeline
GM-Tg-cang-SE1026-Ab-1/ GM-Tg-cang-SE1026-Ab-2Anti-Canine IL27 monoclonal antibodyCanine
GM-Tg-bovg-SE1026-Ab-1/ GM-Tg-bovg-SE1026-Ab-2Anti-Bovine IL27 monoclonal antibodyBovine
GM-Tg-equg-SE1026-Ab-1/ GM-Tg-equg-SE1026-Ab-2Anti-Equine IL27 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1026-Ab-1/ GM-Tg-hg-SE1026-Ab-2; GM-Tg-rg-SE1026-Ab-1/ GM-Tg-rg-SE1026-Ab-2;
GM-Tg-mg-SE1026-Ab-1/ GM-Tg-mg-SE1026-Ab-2; GM-Tg-cynog-SE1026-Ab-1/ GM-Tg-cynog-SE1026-Ab-2;
GM-Tg-felg-SE1026-Ab-1/ GM-Tg-felg-SE1026-Ab-2; GM-Tg-cang-SE1026-Ab-1/ GM-Tg-cang-SE1026-Ab-2;
GM-Tg-bovg-SE1026-Ab-1/ GM-Tg-bovg-SE1026-Ab-2; GM-Tg-equg-SE1026-Ab-1/ GM-Tg-equg-SE1026-Ab-2
Products NameAnti-IL27 monoclonal antibody
Formatmab
Target NameIL27
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IL27 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1026-Ag-1Recombinant multi-species IL27A/ IL27/ IL-27 protein
    ORF Viral VectorvGMLP002772human IL27 Lentivirus particle
    ORF Viral VectorpGMLP002772human IL27 Lentivirus plasmid
    ORF Viral VectorpGMLPm000395mouse Il27 Lentivirus plasmid
    ORF Viral VectorvGMLPm000395mouse Il27 Lentivirus particle


    Target information

    Target IDGM-SE1026
    Target NameIL27
    Gene ID246778,246779,365368,708678,607880,101093822,614927,100066317
    Gene Symbol and SynonymsIL-27,IL-27-A,IL-27A,IL-27alpha,IL-27p28,IL27,IL27-A,IL27A,IL27p28,IL30,p28,RGD1561420
    Uniprot AccessionQ8NEV9
    Uniprot Entry NameIL27A_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseCancer
    Gene EnsemblENSG00000197272
    Target ClassificationTumor-associated antigen (TAA)

    The target: IL27, gene name: IL27, also named as IL-27, IL-27AA, IL27p28, IL30, p28, IL27. The protein encoded by this gene is one of the subunits of a heterodimeric cytokine complex. This protein is related to interleukin 12A (IL12A). It interacts with Epstein-Barr virus induced gene 3 (EBI3), a protein similar to interleukin 12B (IL12B), and forms a complex that has been shown to drive rapid expansion of naive but not memory CD4(+) T cells. The complex is also found to synergize strongly with interleukin 12 to trigger interferon gamma (IFNG) production of naive CD4(+) T cells. The biological effects of this cytokine are mediated by the class I cytokine receptor (WSX1/TCRR). [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.